Profound Medical Corp.
PROF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $147 | $177 | $175 | $194 |
| - Cash | $25 | $35 | $46 | $55 |
| + Debt | $0 | $5 | $5 | $5 |
| Enterprise Value | $123 | $147 | $133 | $144 |
| Revenue | $5 | $2 | $3 | $5 |
| % Growth | 136.6% | -15.6% | -50.8% | – |
| Gross Profit | $4 | $2 | $2 | $4 |
| % Margin | 74.3% | 73.2% | 70.7% | 68.1% |
| EBITDA | -$8 | -$14 | -$11 | -$12 |
| % Margin | -145.8% | -618% | -419.8% | -226.3% |
| Net Income | -$8 | -$16 | -$11 | -$8 |
| % Margin | -150.8% | -709.9% | -409.2% | -144% |
| EPS Diluted | 0.26 | -0.52 | -0.36 | -0.19 |
| % Growth | 150% | -44.4% | -89.5% | – |
| Operating Cash Flow | -$9 | -$14 | -$8 | -$6 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$9 | -$14 | -$8 | -$6 |